The Central Drugs Laboratory, Karachi has achieved WHO prequalification—a significant milestone reflecting its growing capacity to ensure the quality, safety, and efficacy of medicines.
Recent Updates
- Draft Guidance on Quality Control of Sterile Single-Use Syringes (For Comments)October 7, 2026
- DRAP Track & Trace System: Batch Serialization Step-by-Step Video TutorialOctober 6, 2026
- Draft guidelines for establishment of Pharmaceutical unit and Post license variationsOctober 2, 2026
- S.R.O. 1660(I)/2026 (Revised DRAP Regulatory Fee for Therapeutic Goods)October 1, 2026
- Guidelines on Post License Variations (For Comments)September 30, 2026
- Establishment of Pharmaceutical Unit and Post License Changes(For Comments)September 30, 2026
- Due to maintenance work on the fiber-optic line of NTC. DRAP e-Services may remain disrupted today. We regret the inconvenience and appreciate your cooperation.September 29, 2026
- Regulatory Guidance for Local Manufacture Of Biological Products Using Imported Bulk Concentrate or Ready-To-Fill Bulk(For comments)September 29, 2026
- Training of Online Pharmaceutical Track and Trace System for Implementation Of 2-D Barcode and Serialization (For Punjab industry)September 29, 2026
- Important Announcement – Temporary Suspension of Fee Challan ModuleSeptember 29, 2026
- Show all updates
Chief Executive Officer
Dr. Obaidullah

E-Services
With the effective use of Information Technology, we have implemented a number of online services and continually working for more. Click here to browse available services.

Guidelines
Regulatory compliance is essential and indispensable in order to assure the safety, quality and efficacy of therapeutic goods. Guidance documents published by the Authority are meant to explain the current interpretation or policy for better understanding of the industry and

Quality Control Labs
For ensuring quality therapeutic goods, a network of quality control laboratories has been established. DRAP approved products and suspect therapeutic goods are tested for their quality in accordance with best international practices. To keep the citizens safe from substandard and

Health Professional Alerts
DRAP’s issues safety updates and alerts related to the therapeutic goods in order to ensure that healthcare professionals and other stakeholders have timely access to the relevant information on safety, quality and efficacy issues or benefit/risk evaluations of the drugs,

Medicine Availability
The Drug Regulatory Authority of Pakistan (DRAP) is committed to safeguard public health by ensuring the consistent availability of safe, efficacious, and quality medicines nationwide. Recognizing the critical impact of drug shortages, particularly of essential and lifesaving medicines, on patient
Pak-China Pharma & Healthcare B2B Collaboration
Investment Conference 2026. Investment facilitation, company profiling and B2B matchmaking portal. Facilitating technology transfer, joint ventures, and investment partnerships between Pakistani and Chinese pharmaceutical companies for a healthier tomorrow.
Do you know?
DRAP ensures that every drug, medical device or cosmetic, alternative medicine and health product must have a certain standard of quality and is safe and effective for your use. See in links below how it is done and what to do in case you find a suspect therapeutic good.




